Comment on paper ‘Transparency and trust in the European pharmaceutical sector’.

The authors reflect on a report "Transparency and trust in the European pharmaceutical sector" published within issue of the periodical. Topics discussed include relation between transparency and trust in pharmaceutical regulators; need of integrating transparency in effective, evidenced- and science based benefit/risk communication; and need of different regulatory domains to obtain a understanding of the role of the institutional and situational context.